Ultragenyx Pharmaceutical | Stock

Aktienkurs
22.72
Täglich Wechseln
0.89 4.08%
Monatlich
-0.13%
Jährlich
-46.65%
Q1 Prognose
22.02




Stock Veränderung Datum
Acadia Pharmaceuticals USD 29.1M 2.97M 2025-09
Agios Pharmaceuticals USD 32.92M 886K 2025-12
Alnylam Pharmaceuticals USD 82.72M 7.34M 2025-12
BioCryst Pharmaceuticals USD 5.23M 188K 2025-09
BioMarin Pharmaceutical USD 1.38B 42M 2025-09
Esperion Therapeutics USD 108.54M 5.93M 2025-09
Insmed USD 132.07M 11.1M 2025-12
Ionis Pharmaceuticals USD 10.47M 1.99M 2025-09
Karyopharm Therapeutics USD 3.97M 1.03M 2025-09
Kyowa Hakko Kirin JPY 72.86B 304M 2025-06
MacroGenics USD 8.75M 530K 2025-09
Moderna USD 332M 92M 2025-09
Neurocrine Biosciences USD 69M 300K 2025-12
PTC Therapeutics USD 79.65M 26.96M 2025-12
Puma Biotechnology USD 9.48M 885K 2025-09
Regeneron Pharmaceuticals USD 3.2B 53.6M 2025-12
Sarepta Therapeutics USD 1.08B 83.13M 2025-09
Ultragenyx Pharmaceutical USD 52.2M 5.7M 2025-09
Vertex Pharmaceuticals USD 1.69B 60M 2025-12


Ultragenyx Pharmaceutical Stock - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.